
Education
Single Daily HIV Pill Shows Promising Phase 3 Trial Results From UK Research
A Queen Mary University-led trial found a new combined bictegravir-lenacapavir tablet could replace complex multi-drug regimens for…

A Queen Mary University-led trial found a new combined bictegravir-lenacapavir tablet could replace complex multi-drug regimens for…

NHS data shows progress on the 28-day faster diagnosis standard but the 62-day treatment target remains significantly…